Actavis to Sell Some European Operations to Aurobindo Pharma

Actavis Plc agreed to sell its generic drug operations in seven western European countries to India’s Aurobindo Pharma Ltd. as it focuses on other regions including Southeast Asia.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.